Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.
- 1 January 2002
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 59 (3) , 227-230
- https://doi.org/10.1023/a:1019993018162
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular LymphomaJournal of Clinical Oncology, 2001
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.2000
- Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphomaCancer, 1998
- High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?Journal of Clinical Oncology, 1998
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literatureAnnals of Oncology, 1997
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992